$HIPH Which CBD Company is Poised to Become the CV
Post# of 103076
(Total Views: 303)
Posted On: 04/29/2019 11:09:52 AM
$
HIPH
Which CBD Company is Poised to Become the CVSI of 2019?
Is American Premium Water Corporation poised to become the next CV Sciences or New Age Beverage?
New York, NY -- April 29, 2019 -- InvestorsHub NewsWire -- SmallCapTips.com News Commentary --
The CBD market is growing into the mainstream on a daily basis. In March, CVS announced that it would be selling CBD infused products in eight states. Walgreens quickly followed suit, announcing one week later that it would be selling CBD infused products in 1500 of its stores. More big box retailers are expected to follow suit. Whole Foods has begun selling CBD products in select markets while Neiman Marcus and Sephora have begun selling CBD cosmetics. The FDA is expected to give guidance on CBD infused food and beverages at the end of May paving the way for further adaptation of CBD infused products.
New Age Beverages (NASDAQ: NBEV) recently announced that it would begin selling some its Marley branded teas in Wal-Mart, the US's biggest retailer. This distribution agreement positions them to have massive distribution once CBD is widely accepted by traditional retailers. The company also announced last week that it will be begin selling CBD infused topicals, creams, and lotions through a networks of independent distributors. The Company has taken steps to become a fully integrated CBD-infused product company, which had a monumental transformation from OTC penny stock in 2016 to being listed on the NASDAQ the following year. The Company has had increased interest and revenue growth since entering the CBD market last fall.
CV Sciences (OTC: CVSI) recently announced that it has hired Deloitte and Touche LLP, positioning the Company for an uplisting onto the NASDAQ with a Big-5 auditor. This comes after the Company posted $48.24m in revenue for 2018, a 133% increase from 2017. CVSI has established itself as the market leader in CBD oils and pharmaceuticals, and is poised to continue to grow into 2019. CVSI has had rapid price appreciation over the past year and half, when it was trading as low as $0.20 at the end of 2017 and has recently reached highs of $9.20.
Which company currently on the OTC is poised to follow a similar path? Puration, Inc (OTC: PURA) has established itself as one of the first company's to have produced a CBD-infused beverage. PURA received a price target of $0.25 from Goldman Research. Although they have established distribution, they have nowhere near the scale that NBEV had when it made the jump to the NASDAQ. Kona Gold Solutions, Inc (OTC: KGKG) has a similar profile to PURA. Both companies have not made any statements about potentially uplisting and both have not made any progress towards introducing products outside infused beverages like NBEV. Khiron Life Sciences Corporation (OTC: KHRNF) is well positioned for the CBD-infused cosmetics business in the South American market. They have made nice additions to their board of directors, but they are focused on the Latin American market, and have made no statements which direct them to enter the US market or introduce a beverage.
American Premium Water Corporation (OTC: HIPH) has positioned itself to be the next OTC to NASDAQ story and potentially rival NBEV as a market leader in the CBD-infused consumer products sector. HIPH introduced its infused CBD beverage in January 2018 during Super Bowl 52, nine months before NBEV announced that it was developing CBD infused beverages. Additionally HIPH entered the cosmetics business well before NBEV, having acquired Canyon Create in November and subsequently acquiring plant + body essentials last month. Both brands have functional cosmetics that infuse CBD into creams, lotions, topicals, and balms.
The Company's CEO, Ryan Fishoff has stated a desire on numerous occasions for the Company to become fully reporting and uplist to the NASDAQ. In a recent press release, where the HIPH issued FY 2019 guidance of $1 million, Mr. Fishoff stated that the Company continues To focus on uplisting and getting to the NASDAQ by 2020. Mr. Fishoff has also confirmed this is the Company is taking the steps to get fully reporting, tweeting recently he met with the auditing firm Weinberg & Co. He commented in another tweet that he expects the Company to retain them within 20-30 days. Becoming fully reporting combined with a diverse set of CBD infused products, HIPH is on the path to becoming viable for uplist to the NASDAQ to follow NBEV's path.
HIPH is currently priced at $0.03 but last week received financing at a $0.40 valuation. The Company has shown an ability to get exposure at highly visible events and has released an independent study that validates the Company's claims about its proprietary nano-technology. The Company has also expanded to Europe with a partnership with English brewery Hanlon's to make CBD infused beer using HIPH's proprietary nano-formulation. HIPH also stated they have received a significant order from a distributor in the UK, solidifying international distribution on top of growing US distribution. SmallCapTips views HIPH as a standout in the OTC amongst its peers but also a Company that could be battling NBEV within the near future for supremacy in the growing CBD consumer products business and potentially rivaling CVSI from a revenue perspective.
For commentary inquiries, please contact: info@smallcaptips.com
https://ih.advfn.com/p.php?pid=nmona&article=79784797
Is American Premium Water Corporation poised to become the next CV Sciences or New Age Beverage?
New York, NY -- April 29, 2019 -- InvestorsHub NewsWire -- SmallCapTips.com News Commentary --
The CBD market is growing into the mainstream on a daily basis. In March, CVS announced that it would be selling CBD infused products in eight states. Walgreens quickly followed suit, announcing one week later that it would be selling CBD infused products in 1500 of its stores. More big box retailers are expected to follow suit. Whole Foods has begun selling CBD products in select markets while Neiman Marcus and Sephora have begun selling CBD cosmetics. The FDA is expected to give guidance on CBD infused food and beverages at the end of May paving the way for further adaptation of CBD infused products.
New Age Beverages (NASDAQ: NBEV) recently announced that it would begin selling some its Marley branded teas in Wal-Mart, the US's biggest retailer. This distribution agreement positions them to have massive distribution once CBD is widely accepted by traditional retailers. The company also announced last week that it will be begin selling CBD infused topicals, creams, and lotions through a networks of independent distributors. The Company has taken steps to become a fully integrated CBD-infused product company, which had a monumental transformation from OTC penny stock in 2016 to being listed on the NASDAQ the following year. The Company has had increased interest and revenue growth since entering the CBD market last fall.
CV Sciences (OTC: CVSI) recently announced that it has hired Deloitte and Touche LLP, positioning the Company for an uplisting onto the NASDAQ with a Big-5 auditor. This comes after the Company posted $48.24m in revenue for 2018, a 133% increase from 2017. CVSI has established itself as the market leader in CBD oils and pharmaceuticals, and is poised to continue to grow into 2019. CVSI has had rapid price appreciation over the past year and half, when it was trading as low as $0.20 at the end of 2017 and has recently reached highs of $9.20.
Which company currently on the OTC is poised to follow a similar path? Puration, Inc (OTC: PURA) has established itself as one of the first company's to have produced a CBD-infused beverage. PURA received a price target of $0.25 from Goldman Research. Although they have established distribution, they have nowhere near the scale that NBEV had when it made the jump to the NASDAQ. Kona Gold Solutions, Inc (OTC: KGKG) has a similar profile to PURA. Both companies have not made any statements about potentially uplisting and both have not made any progress towards introducing products outside infused beverages like NBEV. Khiron Life Sciences Corporation (OTC: KHRNF) is well positioned for the CBD-infused cosmetics business in the South American market. They have made nice additions to their board of directors, but they are focused on the Latin American market, and have made no statements which direct them to enter the US market or introduce a beverage.
American Premium Water Corporation (OTC: HIPH) has positioned itself to be the next OTC to NASDAQ story and potentially rival NBEV as a market leader in the CBD-infused consumer products sector. HIPH introduced its infused CBD beverage in January 2018 during Super Bowl 52, nine months before NBEV announced that it was developing CBD infused beverages. Additionally HIPH entered the cosmetics business well before NBEV, having acquired Canyon Create in November and subsequently acquiring plant + body essentials last month. Both brands have functional cosmetics that infuse CBD into creams, lotions, topicals, and balms.
The Company's CEO, Ryan Fishoff has stated a desire on numerous occasions for the Company to become fully reporting and uplist to the NASDAQ. In a recent press release, where the HIPH issued FY 2019 guidance of $1 million, Mr. Fishoff stated that the Company continues To focus on uplisting and getting to the NASDAQ by 2020. Mr. Fishoff has also confirmed this is the Company is taking the steps to get fully reporting, tweeting recently he met with the auditing firm Weinberg & Co. He commented in another tweet that he expects the Company to retain them within 20-30 days. Becoming fully reporting combined with a diverse set of CBD infused products, HIPH is on the path to becoming viable for uplist to the NASDAQ to follow NBEV's path.
HIPH is currently priced at $0.03 but last week received financing at a $0.40 valuation. The Company has shown an ability to get exposure at highly visible events and has released an independent study that validates the Company's claims about its proprietary nano-technology. The Company has also expanded to Europe with a partnership with English brewery Hanlon's to make CBD infused beer using HIPH's proprietary nano-formulation. HIPH also stated they have received a significant order from a distributor in the UK, solidifying international distribution on top of growing US distribution. SmallCapTips views HIPH as a standout in the OTC amongst its peers but also a Company that could be battling NBEV within the near future for supremacy in the growing CBD consumer products business and potentially rivaling CVSI from a revenue perspective.
For commentary inquiries, please contact: info@smallcaptips.com
https://ih.advfn.com/p.php?pid=nmona&article=79784797
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
Scroll down for more posts ▼